Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume – Here’s What Happened

Evotec SE (NASDAQ:EVO) saw unusually-strong trading volume on Thursday . Approximately 115,762 shares changed hands during mid-day trading, a decline of 14% from the previous session’s volume of 134,963 shares.The stock last traded at $3.52 and had previously closed at $3.61.

Evotec Trading Down 1.9 %

The company has a debt-to-equity ratio of 0.43, a current ratio of 2.09 and a quick ratio of 1.99. The business’s fifty day simple moving average is $4.17 and its 200 day simple moving average is $4.10.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Wellington Management Group LLP lifted its position in shares of Evotec by 29.7% during the third quarter. Wellington Management Group LLP now owns 2,634,434 shares of the company’s stock worth $9,616,000 after purchasing an additional 602,858 shares during the last quarter. Lighthouse Investment Partners LLC acquired a new position in Evotec during the 4th quarter valued at approximately $166,000. DCF Advisers LLC grew its stake in Evotec by 5.9% during the 4th quarter. DCF Advisers LLC now owns 229,871 shares of the company’s stock worth $956,000 after buying an additional 12,816 shares during the last quarter. CSS LLC IL acquired a new stake in Evotec in the fourth quarter worth $50,000. Finally, Bank of America Corp DE lifted its stake in Evotec by 262.5% in the fourth quarter. Bank of America Corp DE now owns 12,828 shares of the company’s stock valued at $53,000 after buying an additional 9,289 shares during the last quarter. Institutional investors and hedge funds own 5.81% of the company’s stock.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health.